Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps the Government has taken to make an assessment of the potential merits of the use of Vitamin C as a treatment for covid-19.

Although some clinical trial results do show promise for vitamin C to support COVID-19 treatment and recovery, the studies are limited by small sample sizes, early termination of some of the studies, differences in dose and duration, lack of placebo controls, and no pre-and post-intervention plasma vitamin C concentrations. However, vitamin C is currently being trialled in the REMAP-CAP study for patients with COVID-19 acquired pneumonia.